Alpha 2.0
Login Register
» Authors » H M Lazarus

H M Lazarus

Explore the profile of H M Lazarus including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 335
Citations 4244
Followers 0
Related Specialties
General Surgery
Oncology
Hematology
Top 10 Co-Authors
R H Herzig
R P Gale
R J Creger
B W Cooper
G L Phillips
S L Gerson
S N Wolff
J M Rowe
E A Stadtmauer
R M Fox
Published In
Bone Marrow Transplant
J Clin Oncol
Blood
Cancer
Leukemia
Affiliations
Soon will be listed here.
Recent Articles
1.
Intensive post-remission therapy does not decrease relapse after allotransplants for acute myeloid leukaemia in 1st remission and should not be given
Rodriguez-Arboli E, Phillips G, Pardee T, Lazarus H, Gale R
Leukemia . 2025 Mar; PMID: 40074851
No abstract available.
2.
Correction: Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials
Ganzel C, Wang Y, Roopcharan K, Sun Z, Rowe J, Fernandez H, et al.
Bone Marrow Transplant . 2024 Jul; 59(9):1337. PMID: 39025917
No abstract available.
3.
Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials
Ganzel C, Wang Y, Roopcharan K, Sun Z, Rowe J, Fernandez H, et al.
Bone Marrow Transplant . 2024 May; 59(9):1215-1223. PMID: 38778148
Several studies reported that patients with acute myeloid leukemia (AML) who remain in long-term remission after allogeneic or autologous transplant have a shorter life expectancy, compared to the general population....
4.
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy
Gale R, Phillips G, Lazarus H
Leukemia . 2024 Mar; 38(8):1663-1666. PMID: 38459165
No abstract available.
5.
Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes
Tay J, Beattie S, Bredeson C, Brazauskas R, He N, Ahmed I, et al.
Curr Oncol . 2020 Dec; 27(6):e596-e606. PMID: 33380875
Background: Evidence about the impact of marital status before hematopoietic cell transplantation (hct) on outcomes after hct is conflicting. Methods: We identified patients 40 years of age and older within...
6.
Differential expression of interferon-induced genes and other tissue-based biomarkers in acute graft-versus-host disease vs. lupus erythematosus in skin
Lehman J, Dasari S, Damodaran S, El-Azhary R, Gibson L, Hashmi S, et al.
Clin Exp Dermatol . 2018 Oct; 44(4):e81-e88. PMID: 30280423
Background: In both acute graft-versus-host disease (GVHD) and lupus erythematosus (LE), the patient's own tissues are subjected to immunological assault via complex mechanisms influenced by interferon (IFN) and other cytokines....
7.
The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults
Litzow M, Fielding A, Luger S, Paietta E, Ofran Y, Rowe J, et al.
Bone Marrow Transplant . 2017 Jun; 52(12):1592-1598. PMID: 28581459
The introduction of the tyrosine kinase inhibitors (TKI) into the treatment of patients with Ph or BCR-ABL1-positive acute lymphoblastic leukemia has revolutionized the treatment of this poor prognosis acute leukemia....
8.
Nivolumab before and after allogeneic hematopoietic cell transplantation
Covut F, Pinto R, Cooper B, Tomlinson B, Metheny L, Malek E, et al.
Bone Marrow Transplant . 2017 Mar; 52(7):1054-1056. PMID: 28346414
No abstract available.
9.
Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy
Gyurkocza B, Lazarus H, Giralt S
Bone Marrow Transplant . 2017 Mar; 52(8):1083-1090. PMID: 28244979
Patients with acute myeloid leukemia (AML) who fail to achieve complete remission (CR) have a dismal prognosis. Although data suggest that durable remissions can be achieved in approximately 30% of...
10.
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study
Maziarz R, Brazauskas R, Chen M, McLeod A, Martino R, Wingard J, et al.
Bone Marrow Transplant . 2016 Dec; 52(2):270-278. PMID: 27991895
Patients with prior invasive fungal infection (IFI) increasingly proceed to allogeneic hematopoietic cell transplantation (HSCT). However, little is known about the impact of prior IFI on survival. Patients with pre-transplant...